
|Videos|June 29, 2016
Radiosurgery and Immunotherapy for Melanoma Patients With Brain Metastases
Author(s)Veronica L. S. Chiang, MD
In this video we discuss the use of concurrent immunotherapy and stereotactic radiosurgery for treatment of melanoma brain metastases.
Advertisement
A new retrospective study found that patients with melanoma brain metastases who were treated with immunotherapy and stereotactic radiosurgery (SRS) within a month of each other had more robust and rapid tumor shrinkage.
In this video, senior study author Veronica L. S. Chiang, MD, of the Department of Neurosurgery at the Yale School of Medicine in New Haven, Connecticut, discusses the results of the study. Click here to
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Delays Decision on Subcutaneous Isatuximab in Multiple Myeloma
2
Autogene Cevumeran & The Future of Personalized Cancer Vaccines
3
New Frontiers in Adjuvant Care: Evaluating Elacestrant in the ELEGANT Trial
4
CD39/PD-L1 Inhibition May Improve pCR Rate in Resectable NSCLC
5


























































